Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression

Open access

Abstract

Diverse immune cells in the tumor microenvironment form a complex ecosystem, but our knowledge of their heterogeneity and dynamics within hepatocellular carcinoma (HCC) still remains limited. To assess the plasticity and phenotypes of immune cells within HBV/HCV-related HCC microenvironment at single-cell level, we performed single-cell RNA sequencing on 41,698 immune cells from seven pairs of HBV/HCV-related HCC tumors and non-tumor liver tissues. We combined bio-informatic analyses, flow cytometry, and multiplex immunohistochemistry to assess the heterogeneity of different immune cell subsets in functional characteristics, transcriptional regulation, phenotypic switching, and interactions. We identified 29 immune cell subsets of myeloid cells, NK cells, and lymphocytes with unique transcriptomic profiles in HCC. A highly complex immunological network was shaped by diverse immune cell subsets that can transit among different states and mutually interact. Notably, we identified a subset of M2 macrophage with high expression of CCL18 and transcription factor CREM that was enriched in advanced HCC patients, and potentially participated in tumor progression. We also detected a new subset of activated CD8 + T cells highly expressing XCL1 that correlated with better patient survival rates. Meanwhile, distinct transcriptomic signatures, cytotoxic phenotypes, and evolution trajectory of effector CD8 + T cells from early-stage to advanced HCC were also identified. Our study provides insight into the immune microenvironment in HBV/HCV-related HCC and highlights novel macrophage and T-cell subsets that could be further exploited in future immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41421-020-00214-5

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Single-Cell Profiling of diverse immune cells from HCC tumors and distal peri-tumors. a Overview of the study workflow. b, c t-SNE plot and proportions of all 41,698 cells annotated by the seven patients. d, e t-SNE plot and proportions of cell types vary across sample origin from peri-tumor tissues. f, g t-SNE plot and proportions of cell types vary across sample origin from HCC tumor. h Expression of cell-type-specific marker genes illustrated in t-SNE plots.
Fig. 1 Single-Cell Profiling of diverse immune cells from HCC tumors and distal peri-tumors. a Overview of the study workflow. b, c t-SNE plot and proportions of all 41,698 cells annotated by the seven patients. d, e t-SNE plot and proportions of cell types vary across sample origin from peri-tumor tissues. f, g t-SNE plot and proportions of cell types vary across sample origin from HCC tumor. h Expression of cell-type-specific marker genes illustrated in t-SNE plots.CC BY · PubMed Central
Fig. 2 Identifying distinct myeloid cell clusters in HCC. a t-SNE projection of eight subsets of myeloid cells (each dot corresponds to one single cell) shown in different colors. b t-SNE plots of different myeloid cell clusters origin. c Expression of marker genes for each cluster illustrated in the t-SNE plots. d Heatmap of the differences in pathway activities scored per cell by GSVA analysis. e Representative mIHC images to show the distribution of CD68+CD206+CCL18+ macrophages: CD68 (yellow), CD206 (green), CCL18 (red), and DAPI (bule). White arrows (CD68+CD206+CCL18+), blue arrow (CD68+CD206+CCL18−). Scale bar, 50 μm. f Kaplan–Meier curve showing poor survival in patients with high proportion of CD68+CD206+CCL18+ macrophage vs low proportion (log-rank test, P = 0.001) in our cohort. g Kaplan–Meier curves of survival for the TCGA HCC patients grouped by the average expression (high versus low) of DC_c1_CLEC9A cell marker genes as annotated in Table S3. (log-rank test, P = 0.0036). h Volcano plot showing differentially expressed genes in DC_c1_CLEC9A cells between peri-tumor and tumor. Each red dot denotes an individual gene passing our P value and fold change thresholds.
Fig. 2 Identifying distinct myeloid cell clusters in HCC. a t-SNE projection of eight subsets of myeloid cells (each dot corresponds to one single cell) shown in different colors. b t-SNE plots of different myeloid cell clusters origin. c Expression of marker genes for each cluster illustrated in the t-SNE plots. d Heatmap of the differences in pathway activities scored per cell by GSVA analysis. e Representative mIHC images to show the distribution of CD68+CD206+CCL18+ macrophages: CD68 (yellow), CD206 (green), CCL18 (red), and DAPI (bule). White arrows (CD68+CD206+CCL18+), blue arrow (CD68+CD206+CCL18−). Scale bar, 50 μm. f Kaplan–Meier curve showing poor survival in patients with high proportion of CD68+CD206+CCL18+ macrophage vs low proportion (log-rank test, P = 0.001) in our cohort. g Kaplan–Meier curves of survival for the TCGA HCC patients grouped by the average expression (high versus low) of DC_c1_CLEC9A cell marker genes as annotated in Table S3. (log-rank test, P = 0.0036). h Volcano plot showing differentially expressed genes in DC_c1_CLEC9A cells between peri-tumor and tumor. Each red dot denotes an individual gene passing our P value and fold change thresholds.CC BY · PubMed Central
Fig. 3 Transcriptome heterogeneity of four subsets of macrophages. a Module scores of M1 and M2 expression signatures defined by Azizi et al.14 (Genes list in Supplementary Table S5) for each macrophage subset at single-cell level. *P < 0.01. b t-SNE plots of M1 (top) and M2 (bottom) expression signatures. c The expression of lipid metabolism-related genes plotted via boxplots. *P < 0.01. d t-SNE plots for the expression of CREM and regulation of its target genes. e Representative flow cytometry plots (top) and statistics (bottom) of CREM expression in CD14+CD11b+ macrophages from HCC tumor or peri-tumor, and CD14+CD11b+CD206− or CD14+CD11b+CD206+ macrophages. Data analyzed by wilcoxon matched-pairs signed rank test. *P < 0.05, **P < 0.01.
Fig. 3 Transcriptome heterogeneity of four subsets of macrophages. a Module scores of M1 and M2 expression signatures defined by Azizi et al.14 (Genes list in Supplementary Table S5) for each macrophage subset at single-cell level. *P < 0.01. b t-SNE plots of M1 (top) and M2 (bottom) expression signatures. c The expression of lipid metabolism-related genes plotted via boxplots. *P < 0.01. d t-SNE plots for the expression of CREM and regulation of its target genes. e Representative flow cytometry plots (top) and statistics (bottom) of CREM expression in CD14+CD11b+ macrophages from HCC tumor or peri-tumor, and CD14+CD11b+CD206− or CD14+CD11b+CD206+ macrophages. Data analyzed by wilcoxon matched-pairs signed rank test. *P < 0.05, **P < 0.01.CC BY · PubMed Central
Fig. 4 Different NK subpopulations in HCC tumor and peri-tumor. a t-SNE plot of all NK cells revealed six distinct NK clusters. b t-SNE plots of different NK cell clusters origin. c Expression of canonical marker genes in six NK cell populations. d Module scores of CD56bright and CD56dim expression programs defined by Hanna et al.33 for each NK cell. e Violin plots representing the distribution module score for CD56dim (left) and CD56bright (right) for each NK cluster. Error bars indicated the means ± SD. f Trajectory of all clusters of NK cell from tumor sites along pseudotime in a two-dimensional state-space defined by Monocle2. Each point corresponds to a single cell, and each color represents a NK cell cluster. g Differentially expressed genes (rows) along the pseudotime (left) and boxplots showing the expression of CXCR6, XCL1, CX3CR1, and FGFBP2 (right).
Fig. 4 Different NK subpopulations in HCC tumor and peri-tumor. a t-SNE plot of all NK cells revealed six distinct NK clusters. b t-SNE plots of different NK cell clusters origin. c Expression of canonical marker genes in six NK cell populations. d Module scores of CD56bright and CD56dim expression programs defined by Hanna et al.33 for each NK cell. e Violin plots representing the distribution module score for CD56dim (left) and CD56bright (right) for each NK cluster. Error bars indicated the means ± SD. f Trajectory of all clusters of NK cell from tumor sites along pseudotime in a two-dimensional state-space defined by Monocle2. Each point corresponds to a single cell, and each color represents a NK cell cluster. g Differentially expressed genes (rows) along the pseudotime (left) and boxplots showing the expression of CXCR6, XCL1, CX3CR1, and FGFBP2 (right).CC BY · PubMed Central
Fig. 5 Infiltration of diverse CD8+ T-cell subsets in HCC. a t-SNE projection of all CD8+ T cells showed in different colors. b t-SNE plots of different subsets of CD8+ T-cell origin. c Proportions of five clusters in each patient. d Expression of marker genes for each cluster illustrated in the t-SNE plots. e Multicolor IHC staining to validate the existence of CD3+CD8+CD56−XCL1+ T cells in HCC TME, white arrows (CD3+CD8+CD56−XCL1+). Scale bar, 20 μm. f Kaplan–Meier curve showing decreased survival in patients with low proportion of CD3+CD8+CD56−XCL1+ T cells (Log-rank test) in our cohort (Supplementary Table S4). g Pseudotime trajectory of early-stage or late-stage CD8_c1 T cells demonstrated in the trajectory. h Expression of selected genes in early-stage and late-stage HCC are shown in the boxplots. *P < 0.01.
Fig. 5 Infiltration of diverse CD8+ T-cell subsets in HCC. a t-SNE projection of all CD8+ T cells showed in different colors. b t-SNE plots of different subsets of CD8+ T-cell origin. c Proportions of five clusters in each patient. d Expression of marker genes for each cluster illustrated in the t-SNE plots. e Multicolor IHC staining to validate the existence of CD3+CD8+CD56−XCL1+ T cells in HCC TME, white arrows (CD3+CD8+CD56−XCL1+). Scale bar, 20 μm. f Kaplan–Meier curve showing decreased survival in patients with low proportion of CD3+CD8+CD56−XCL1+ T cells (Log-rank test) in our cohort (Supplementary Table S4). g Pseudotime trajectory of early-stage or late-stage CD8_c1 T cells demonstrated in the trajectory. h Expression of selected genes in early-stage and late-stage HCC are shown in the boxplots. *P < 0.01.CC BY · PubMed Central
Fig. 6 Increased cell–cell interactions occurring in the HCC TME. a Overview of selected ligand–receptor interactions which presented specifically in HCC tumors. P values indicated by circle size (permutation test). The means of the average expression level of interactions are indicated by color. The cell types below the line are the ligand cells, and the cell types above the line are the corresponding receptor cells. b Selected interactions of ligand-receptor pairs in HCC TME. The line color indicates ligands broadcast by the cell population of the same color. Lines connect to cell populations where cognate receptors are expressed. The line thickness is proportional to the number of ligands where cognate receptors are present in the recipient cell population.
Fig. 6 Increased cell–cell interactions occurring in the HCC TME. a Overview of selected ligand–receptor interactions which presented specifically in HCC tumors. P values indicated by circle size (permutation test). The means of the average expression level of interactions are indicated by color. The cell types below the line are the ligand cells, and the cell types above the line are the corresponding receptor cells. b Selected interactions of ligand-receptor pairs in HCC TME. The line color indicates ligands broadcast by the cell population of the same color. Lines connect to cell populations where cognate receptors are expressed. The line thickness is proportional to the number of ligands where cognate receptors are present in the recipient cell population.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 175

Metadata

Authors
Song, G., Shi, Y., Zhang, M., Goswami, S., Afridi, S., Meng, L., Ma, J., Chen, Y., Lin, Y., Zhang, J., Liu, Y., Jin, Z., Yang, S., Rao, D., Zhang, S., Ke, A., Wang, X., Cao, Y., Zhou, J., Fan, J., Zhang, X., Xi, R., & Gao, Q.
Affiliations
  • Fudan University (CN)
  • Peking University (CN)
  • Chinese Academy of Sciences (CN)
  • Second Affiliated Hospital of Nantong University (CN)
  • Central South University (CN)
  • Shanghai Medical College of Fudan University (CN)
Corresponding author
  • Zhang, Xiaoming
  • Xi, Ruibin
  • Gao, Qiang
Venue
Cell Discovery
Published
2020-12-08
Volume
6
Issue
1
Pages
90-90
ISSN
2056-5968 (ISSN-L)
OpenAlex
W3112241151
Cited by
175
References
46
Citations by year
2026: 12 · 2025: 27 · 2024: 54 · 2023: 37 · 2022: 30 · 2021: 15
FWCI
8.57
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Discovery (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Greater South Information System
Funders
  • National Natural Science Foundation of China (81872321, 81961128025, 91859105)
  • Chinese Academy of Sciences (XDB29030302)
  • Program of Shanghai Academic Research Leader
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
hepatocellular carcinoma, HBV-related liver cancer, HCV-associated liver cancer, tumor immune microenvironment, M2 macrophages, CCL18, CREM, CD8+ T cells, XCL1, natural killer cells, myeloid cells, immune cell heterogeneity, disease progression, patient survival, immunotherapy targets

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression. https://app.cochat.ai/papers/10.1038/s41421-020-00214-5
The paper
Song, G., Shi, Y., Zhang, M., Goswami, S., Afridi, S., Meng, L., Ma, J., Chen, Y., Lin, Y., Zhang, J., Liu, Y., Jin, Z., Yang, S., Rao, D., Zhang, S., Ke, A., Wang, X., Cao, Y., Zhou, J., . . . Gao, Q. (2020). Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression. Cell Discovery. https://doi.org/10.1038/s41421-020-00214-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.